Context Therapeutics Inc.·4

Dec 19, 4:22 PM ET

Minai-Azary Jennifer Lynn 4

4 · Context Therapeutics Inc. · Filed Dec 19, 2022

Insider Transaction Report

Form 4
Period: 2022-12-16
Minai-Azary Jennifer Lynn
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2022-12-16$0.74/sh+25,000$18,50040,000 total

Documents

1 file
  • 4
    wf-form4_167148450192465.xmlPrimary

    FORM 4